Lucy Gilbert
McGill University Health Centre(CA)McGill University(CA)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer(2016)2,417 cited
- → Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer(2023)738 cited
- → Clinical Activity and Safety of the Anti–Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair–Deficient Endometrial Cancer(2020)349 cited
- → Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial(2024)313 cited
- → Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study(2022)305 cited
- → Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial